Common clinical markers predict end-stage renal disease in children with obstructive uropathy

Daryl J McLeod1,2, Christina B Ching3,4, Yuri V Sebastião5

  • 1Section of Urology, Nationwide Children's Hospital, Columbus, OH, 43205, USA. Daryl.mcleod@nationwidechildrens.org.

Insights

Obstructive uropathy in children with mild-to-moderate chronic kidney disease can be predicted to progress to end-stage renal disease using readily available clinical markers. Early identification aids in managing pediatric kidney disease progression.

Area of Science:

  • Pediatric Nephrology
  • Urology
  • Chronic Kidney Disease Research

Background:

  • Obstructive uropathy (OU) is a significant cause of end-stage renal disease (ESRD) in the pediatric population.
  • Children with mild-to-moderate chronic kidney disease (CKD) secondary to OU face ongoing risks for disease progression.
  • Predictive capabilities of standard clinical markers for OU-related CKD progression in children are not well-defined.

Purpose of the Study:

  • To evaluate the predictive value of baseline and longitudinal clinical markers for the progression to ESRD in children with OU and mild-to-moderate CKD.
  • To identify key indicators that signify a higher risk of renal replacement therapy (RRT) in this cohort.

Main Methods:

  • A cohort of patients with obstructive uropathy was identified within the Chronic Kidney Disease in Children Study.
  • Cases were defined as patients requiring renal replacement therapy (RRT), while age-matched controls did not require RRT during follow-up.
  • Analysis included comparison of baseline and longitudinal data for glomerular filtration rate (GFR), urine protein/creatinine, microalbumin/creatinine, serum CO2, hemoglobin, phosphate, and albumin.

Main Results:

  • Significant differences were observed between cases and controls in baseline GFR, urine protein/creatinine, microalbumin/creatinine, serum CO2, and hemoglobin.
  • Cases exhibited a faster annual decline in GFR (3.07 mL/min/1.73 m²/year) compared to controls.
  • Cases also showed a greater annual increase in urine protein/creatinine and microalbumin/creatinine, and a greater annual increase in serum phosphate and decrease in hemoglobin and albumin.

Conclusions:

  • Readily available clinical measures, assessed at baseline and longitudinally, can predict the progression to ESRD in children with mild-to-moderate CKD from obstructive uropathy.
  • These findings highlight the importance of monitoring specific biomarkers for risk stratification and timely intervention in pediatric patients with OU.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.5K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.7K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.2K
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
5.1K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.7K